Auburn studying hepatitis vaccine for canine osteosarcoma

05/9/2013 | AL.com (Alabama)

The Auburn University Research Initiative in Cancer is conducting a study to assess whether a modified hepatitis vaccine can destroy canine cancer cells. Twenty owned dogs with osteosarcoma that have not yet undergone limb amputation will be involved in the study. Researchers hope to use the technique to treat numerous types of cancer in dogs and humans. "Dogs get skin cancer, dogs get blood cancers that are similar to human cancers, dogs get brain cancers ... similar to human cancers ... so what we learn in dogs is very applicable to humans," said veterinarian Bruce Smith, who directs the initiative.

View Full Article in:

AL.com (Alabama)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC
Manager/Senior Manager, Health Economist
Avalere Health
Washington, DC
Director, Health Services Analytics
Avalere Health
Washington, DC
Director/Vice President. Health Actuary
Avalere Health
Washington, DC
Director of Governmental Programs
Bluegrass Family Health
Lexington, KY